Bespak began by supplying valves for cosmetics and consumer markets (King’s Lynn).
Gained contract with GSK for Ventolin, thus entering the pharmaceutical market.
Moved to King’s Lynn where Bespak remains today.
Awarded Diskus® manufacturing contract by GSK.
Launched HFA valve to replace CFC variant.
Awarded Chiesi Nexthaler Development and Manufacturing contract
Bespak acquires Integrated Aluminium Components
Bespak acquires The Medical House, a specialist in auto injectors.
500 millionth Diskus® device manufactured for GSK.
Entered point of care diagnostics market in partnership with Atlas Genetics.
Entered point of care diagnostics market in partnership with Binx Healthcare
Acquisition of Aesica Pharmaceuticals by Consort Medical plc.
Regulatory approval and launch of Bespak’s first auto-injector.
Agreement with SteadyMed for development of wearable infusion delivery device.
2 billionth HFA MDI Valve manufactured.
Bespak brings into operation, at it’s King’s Lynn site, the UK’s largest cleanroom at the time of construction.
Development agreement with Precision Ocular.
Unveiled Syrina® VapourSoft® 2.25ml injection devices.
Announced industrialisation and manufacture of Mylan DPI.
Regulatory approval and UK launch for UCB autoinjector with Bespak ASI® technology.
Signed AstraZeneca pMDI agreement.
750 millionth Diskus® device manufactured for GSK.
Bespak Injection Moulding Academy opened.
Awarded Regeneron contract
FDA approval for Mylan’s generic Advair
Bespak acquired by Recipharm
FDA approval of Oral Integrated Dose Counter